Dr. Joseph M. Chalil, MD, MBA, FACHE, Best Selling Author and Publisher of The Universal News Network, (www.theunn.com) has been appointed as the Chief Medical Officer of Novo Integrated Sciences, Inc. (NASDAQ: NVOS) and the New President of Novomerica Health Group, Inc on April 5th, 2022. In addition, Dr, Chalil will maintain his leadership of Clinical Consultants International LLC (CCI).
While announcing the appointment, Robert Mattacchione, Novo’s CEO and Board Chairman of Novo Integrated Sciences, Inc. stated, “Adding CCI and the impressive CCI team of highly respected, proven leaders in the medical community, led by Dr. Chalil, is a significant milestone intended to accelerate Novo’s expansion to both the U.S. and other global markets. As the healthcare sector worldwide is facing increasingly complex demands with incredible opportunities to leverage technology and new service models, Dr. Chalil and the CCI team are the perfect partner to accelerate the growth of Novo’s decentralized healthcare delivery business model.
Dr. Chalil and his team share Novo’s forward-thinking vision and combined with CCI’s exceptional talent undoubtedly make CCI a strong addition to the Novo portfolio of companies.” Novo Integrated Sciences, Inc. is pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of services and product innovation.
Under the terms of Novo’s acquisition, CCI will be a wholly owned subsidiary of the Company. CCI has an impressive international team of physician leaders, diplomats, hospital administrators, and regulatory/FDA experts.
“Working with Rob and the Novo team over the last year, I’ve witnessed firsthand Novo’s commitment to be a leader in the ongoing transformation of healthcare delivery worldwide,” said Dr. Chalil. “I cannot think of a better partnership for CCI and the CCI team and it is my honor to join the Novo team with this acquisition. I am excited to work closely with Rob and the Novo team to implement our shared vision for the path forward to improving access to high-quality healthcare services and products worldwide.”
Founded in 2006, the highly respected CCI senior strategic advisor team includes Ambassador Pradeep K. Kapur, IFS (IIT Delhi), former Indian Ambassador to several countries including Chile, Dr. Zach P. Zachariah, MD, Medical Director of Health Cardiology, and the longest-serving member of the Florida Board of Medicine, Saju George, CEO for Garden City Hospital and Prime Healthcare’s midwestern region, and other professionals with extensive healthcare and hospital management experience.
Dr.Chalil served as Chairman of Novo’s Medical Advisory Board since April ‘2021. Dr. Chalil is an author of several scientific and research papers in international publications. He is also the Chairman of the Complex Health Systems Advisory Board, H. Wayne Huizenga College of Business and Entrepreneurship at Nova Southeastern University in Florida, and a member of Dr. Kiran C. Patel College of Allopathic Medicine Executive Leadership Council.
A veteran of the U.S. Navy Medical Corps, he is board certified in healthcare management. He has been awarded a Fellowship by the American College of Healthcare Executives, an international professional society of more than 40,000 healthcare executives who lead hospitals, healthcare systems, and other healthcare organizations. Dr.Chalil has held roles of increasing responsibility at DBV Technologies, Boehringer Ingelheim, Abbott Laboratories, and Hoffmann-La Roche.
Additionally, Dr.Chalil is the former Chairman of the Indo-American Press Club. He is an expert in U.S. healthcare policy and a strong advocate for patient-centered care. A strong proponent of providing healthcare access to everyone, Dr. Chalil’s new book, Beyond the COVID-19 Pandemic: Envisioning a Better World by Transforming the Future of Healthcare, is on Amazon’s Best Sellers List.
